Quality of life instruments used in problem gambling studies: A systematic review and a meta-analysis
Introduction
Problem gambling is characterized by a persistent and recurrent problematic gambling behavior leading to clinically significant impairment or distress (Browne et al., 2016). However treatment outcomes in this field remain poorly defined and are measured inconsistently across studies (Pickering et al., 2017). This is probably due to no consensual definition of recovery, as remission is only defined by no diagnostic operatory criterion during twelve months (American Psychiatric Association, 2013). Moreover, the course of the disease can vary deeply from one subject to another, as attests DSM-5 specification of the diagnosis “episodic” or “persistent”. Gambling disorder does not follow a linear course over time (Bruneau et al., 2016; LaPlante et al., 2008; Slutske et al., 2003). A wide range of outcome measures is used in gambling disorder research (Walker et al., 2006). A recent systematic review identified sixty-three different outcome measures in gambling disorder studies (Pickering et al., 2017). Their authors recommend developing a multidimensional scale that could assess the efficacy of an intervention in various domains of functioning (Pickering et al., 2017). Earlier, the Banff Consensus provided a framework with the minimum features of reporting efficacy of intervention and came to support the relevance of quality of life assessment in gambling disorder, in complement with the reduction of gambling behavior and the reduction of problems caused by gambling (Walker et al., 2006).
In 1993, the World Health Organization defined quality of life (QOL) “as an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. It is a broad ranging concept affected in a complex way by the person's physical health, psychological state, level of independence, social relationships, and their relationship to salient features of their environment” (Szabo and WHOQOL Group, 1996). Two types of QOL instruments are usually used: (i) general QOL instruments exploring overall QOL regardless of any health condition and (ii) health-related QOL (HRQOL) classically involving four areas: physical, physical well-being, psychological state and social relations (Leplège, 1999). On one hand, “quality of life" describes a subjective feeling of satisfaction with life in domains of importance to the subjects. On the other hand, “health-related quality of life” reports a subjective perception of the impact of the disease and its treatment(s) on daily life, physical, psychological and social functioning and well-being (Leidy et al., 1999).
QOL has been discussed in the medical literature since the 1960s (Elkinton, 1966). It became increasingly important in heath care to measure outcomes beyond morbidity and biological functioning (Karimi and Brazier, 2016). The practice of medicine is often based on the identification and management of symptoms, while patients' expectations go beyond management of symptoms: they are looking for optimal well-being (Luquiens and Aubin, 2014). In addiction, QOL assessment matches with the treatment goal of enhanced client functioning and predict treatment adherence (Laudet, 2011). Moreover, participants with addiction at all stages of recovery expressed concerns about multiple areas of functioning (Laudet et al., 2009). QOL is often included as a secondary endpoint in clinical trials, reflecting patients’ feelings and functioning and the impact of their health condition beyond simple symptom assessment (Carr et al., 2001). In 2006, Walker et al. stressed that there was a lack of evaluated or validated psychometric instruments assessing QOL in gambling disorder (Walker et al., 2006) whereas evaluated or validated psychometric instruments assessing QOL do exist in substance use disorders (Luquiens et al., 2016; Neale et al., 2016).
The purpose of this review was (i) to identify the instruments used in original articles to measure QOL/HRQOL in subjects with a gambling disorder in all original articles and then (ii) to assess the suitability of these instruments (reliability, content validity, effect size) in the gambling disorder field.
Section snippets
Material and methods
The systematic review was conducted independently using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines for systematic reviews (Liberati et al., 2009). Our review project was registered in PROSPERO database. Our project began in 2016. Since then, we have updated our review and implemented it with a meta-analysis. So we have updated our record in PROSPERO database (https://www.crd.york.ac.uk/PROSPERO/#recordDetails).
Results
The search yielded 423 citations, published between 1997 and 2018. Of these, 221 were ineligible after review of the title and abstract. Thirty-five studies were included in this review. The PRISMA flow diagram of the study selection process (Fig. 1) shows the reasons for excluding articles. The thirty-five included articles were published between 2002 and 2017. We identified six types of instruments aiming at measure QOL or HRQOL - all instruments self-administered:
- •
The Medical Outcomes Study
Discussion
To our knowledge, this is the first review that inventories and assesses the suitability of QOL/HRQOL instruments in the gambling problem. We reviewed randomized controlled trials, non-comparative trials and epidemiological studies in order to be as comprehensive as possible. We explored the suitability of these instruments through their psychometric properties and their content. In addition, we performed a meta-analysis to analyze their global effect size compared to the effect size of
Conclusion
A successful intervention can be indirectly measured by consequent increases in the QOL. The currently used general instruments are efficient to measure a significant change after an intervention but might not evaluate specific areas of health related QOL impacted by gambling disorders. Moreover, they are not totally validated in the problem gambling population and are probably less sensitive than gambling behavioral criteria. Despite being self-administered and requesting subjective answers,
Funding source
Nothing declared.
References (83)
- et al.
A prospective follow-up study of younger and older subjects with pathological gambling
Psychiatry Res.
(2017) - et al.
Pathological gambling: relationship to obesity, self-reported chronic medical conditions, poor lifestyle choices, and impaired quality of life
Compr. Psychiatry
(2013) - et al.
Neurocognitive dysfunction in problem gamblers with co-occurring antisocial personality disorder
Compr. Psychiatry
(2017) - et al.
The estimation of a preference-based measure of health from the SF-36
J. Health Econ.
(2002) - et al.
Deriving a preference-based single index from the UK SF-36 Health Survey
J. Clin. Epidemiol.
(1998) - et al.
Gambling transitions among adult gamblers: a multi-state model using a Markovian approach applied to the JEU cohort
Addict. Behav.
(2016) - et al.
Latent class analysis of gambling subtypes and impulsive/compulsive associations: time to rethink diagnostic boundaries for gambling disorder?
Addict. Behav.
(2017) - et al.
Quality of life in kleptomania and pathological gambling
Compr. Psychiatry
(2005) - et al.
Recommendations for evaluating the validity of quality of life claims for labeling and promotion
Value Health J. Int. Soc. Pharmacoeconomics Outcomes Res.
(1999) - et al.
Suicidal ideation and lifetime attempts in substance and gambling disorders
Psychiatry Res.
(2015)
Development and validation of “SURE”: a patient reported outcome measure (PROM) for recovery from drug and alcohol dependence
Drug Alcohol Depend.
Graphic representation of pain
Pain
Comorbid physical and mental illnesses among pathological gamblers: results from a population based study in Singapore
Psychiatry Res.
Problem gambling subtypes based on psychological distress, alcohol abuse and impulsivity
Addict. Behav.
The Italian translation of the celiac disease-specific quality of life scale in celiac patients on gluten free diet
Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver
2013. Diagnostic and Statistical Manual of Mental Disorders
The FDA guidance for industry on PROs: the point of view of a pharmaceutical company
Health Qual. Life Outcomes
Quality of life and family history in pathological gambling
J. Nerv. Ment. Dis.
Giving room to subjectivity in understanding and assessing problem gambling: a patient-centered approach focused on quality of life
J. Behav. Addict.
Measuring the Burden of Gambling Harm in New Zealand
Assessing Gambling-related Harm in Victoria: a Public Health Perspective [WWW Document]
Internet-based treatment of pathological gambling with a three-year follow-up
Cogn. Behav. Ther.
Randomized trial of internet-delivered self-help with telephone support for pathological gamblers
J. Consult. Clin. Psychol.
Measuring quality of life: Is quality of life determined by expectations or experience?
BMJ
White matter tract integrity in treatment-resistant gambling disorder
Br. J. Psychiatry J. Ment. Sci.
Disordered (pathologic or problem) gambling and axis I psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions
Am. J. Epidemiol.
Statistical Power Analysis for the Behavioral Sciences
Developing a National Index of Subjective Wellbeing: The Australian Unity Wellbeing Index
Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
Biometrics
A nationwide study of health-related quality of life, stress, pain or discomfort and the use of medicine among problem gamblers
Scand. J. Public Health
Medicine and the quality of life
Ann. Intern. Med.
Quality of life enjoyment and satisfaction questionnaire: a new measure
Psychopharmacol. Bull.
EuroQol--a new facility for the measurement of health-related quality of life
Health Policy Amst. Neth.
Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
Clinical validation of the Quality of Life Inventory. A measure of life satisfaction for use in treatment planning and outcome assessment
Psychol. Assess.
Development and validation of a disease-specific scale to assess psychosocial well-being of patients living with unruptured intracranial aneurysm
J. Neurosci. Nurs. J. Am. Assoc. Neurosci. Nurses
The efficacy of motivational intervention and cognitive-behavioral therapy for pathological gambling
Adicciones
Gambling disorder and its relationship with substance use disorders: implications for nosological revisions and treatment
Am. J. Addict.
Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation
Int. Clin. Psychopharmacol.
An analysis of treatment-seeking behavior in individuals with gambling disorder
J. Gambl. Stud.
Cited by (6)
The Role of Social Support and Belonging in Predicting Recovery from Problem Gambling
2023, Journal of Gambling StudiesDevelopment and Psychometric Properties of a New Patient-Reported Outcome Instrument of Health-Related Quality of Life Specific to Patients with Gambling Disorder: The Gambling Quality of Life Scale (GQoLS)
2022, International Journal of Environmental Research and Public HealthIs there a health inequality in gambling related harms? A systematic review
2021, BMC Public HealthAssessment tools for life quality in chronic kidney disease patients undergoing hemodialysis. A systematic review
2020, Revista de Nefrologia, Dialisis y Trasplante